{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:40:33Z","timestamp":1790350833309,"version":"4.1.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005971","name":"German Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Foundation of Heart Research"},{"DOI":"10.13039\/501100020278","name":"EU","doi-asserted-by":"publisher","award":["633196"],"award-info":[{"award-number":["633196"]}],"id":[{"id":"10.13039\/501100020278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020278","name":"EU","doi-asserted-by":"publisher","award":["847770"],"award-info":[{"award-number":["847770"]}],"id":[{"id":"10.13039\/501100020278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020278","name":"EU","doi-asserted-by":"publisher","award":["965286"],"award-info":[{"award-number":["965286"]}],"id":[{"id":"10.13039\/501100020278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["AA\/18\/2\/34218"],"award-info":[{"award-number":["AA\/18\/2\/34218"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/17\/30\/32961"],"award-info":[{"award-number":["PG\/17\/30\/32961"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/20\/22\/35093"],"award-info":[{"award-number":["PG\/20\/22\/35093"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["AA\/18\/2\/34218"],"award-info":[{"award-number":["AA\/18\/2\/34218"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Ministry of Education and Research"},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union BigData@Heart","award":["EU IMI 116074"],"award-info":[{"award-number":["EU IMI 116074"]}]},{"name":"European Union BigData@Heart","award":["847770"],"award-info":[{"award-number":["847770"]}]},{"name":"MAESTRIA","award":["965286"],"award-info":[{"award-number":["965286"]}]},{"name":"German Ministry of Education and Research"},{"DOI":"10.13039\/501100001674","name":"Leducq Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union\u2019s Horizon 2020 research and innovation","award":["648131"],"award-info":[{"award-number":["648131"]}]},{"name":"European Union\u2019s Horizon 2020 research and innovation","award":["847770"],"award-info":[{"award-number":["847770"]}]},{"DOI":"10.13039\/100010447","name":"German Center for Cardiovascular Research","doi-asserted-by":"publisher","award":["81Z1710103"],"award-info":[{"award-number":["81Z1710103"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"German Center for Cardiovascular Research","doi-asserted-by":"publisher","award":["81Z0710114"],"award-info":[{"award-number":["81Z0710114"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Ministry of Research and Education","award":["BMBF 01ZX1408A"],"award-info":[{"award-number":["BMBF 01ZX1408A"]}]},{"name":"ERACoSysMed3","award":["031L0239"],"award-info":[{"award-number":["031L0239"]}]},{"DOI":"10.13039\/501100000555","name":"BMS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Biomarkers have the potential to improve risk prediction beyond clinical characteristics. We examined the association of four emerging cardiovascular biomarkers [angiopoietin 2 (Angpt2), bone morphogenetic protein 10 (BMP10), fibroblast growth factor 23 (FGF23), insulin-like growth factor binding protein 7 (IGFBP7)] in comparison with N-terminal pro B-type natriuretic peptide (NT-proBNP) across the disease course of atrial fibrillation (AF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We enrolled patients from a prospective cohort of patients at risk of AF or with manifest arrhythmia. The circulating vascular biomarkers were quantified using high-throughput, high-precision precommercial assays (Roche Diagnostics). A combined endpoint comprised: stroke, transient ischaemic attack (TIA), myocardial infarction, incident coronary heart disease, heart failure, and all-cause mortality. Of the total n = 1047 individuals, n = 527 had prevalent AF, and n = 507 were free of AF at baseline. Median follow-up was 42 months. A total of n = 66 individuals died; the combined endpoint occurred in n = 198 individuals. All five biomarkers were significantly associated with the incidence of AF, both in multistate analysis (MSA) and Cox regression, although the association with FGF23 was only significant in the age- and sex-adjusted Cox model. AF recurrence was significantly associated with all biomarkers, most strongly with NT-proBNP. In prevalent AF, NT-proBNP, FGF23, and IGFBP7 were associated with the combined endpoint and all-cause mortality, and Angpt2 was associated with all-cause mortality. NT-proBNP showed the strongest association for all-cause mortality, and IGFBP7 for the combined endpoint in prevalent AF. In incident AF the association with the combined outcome was statistically significant for NT-proBNP in multivariable-adjusted models. All-cause mortality in individuals with incident AF was associated with NT-proBNP, Angpt2, FGF23, and IGFBP7 both in the MSA and Cox model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>All novel biomarkers Angpt2, BMP10, FGF23, and IGFBP7 showed predictive value for incident and recurrent AF. Individual biomarkers showed distinct strengths in prediction of outcomes across the disease spectrum of AF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euag096","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:34:40Z","timestamp":1777376080000},"source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive assessment of novel cardiovascular biomarkers in AF"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3969-624X","authenticated-orcid":false,"given":"Amelie H","family":"Ohlrogge","sequence":"first","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research (DZHK), Partner Site North , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9519-6258","authenticated-orcid":false,"given":"Daniel","family":"Engler","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research (DZHK), Partner Site North , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4963-0319","authenticated-orcid":false,"given":"Patricia","family":"Schlieker","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research (DZHK), Partner Site North , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4595-1531","authenticated-orcid":false,"given":"Ferdinand","family":"Seum","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research (DZHK), Partner Site North , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Rosebrock","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research (DZHK), Partner Site North , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2076-6887","authenticated-orcid":false,"given":"Nicole","family":"Nebel","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6210-349X","authenticated-orcid":false,"given":"Dora","family":"Csengeri","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research (DZHK), Partner Site North , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9241-1733","authenticated-orcid":false,"given":"Larissa","family":"Fabritz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research (DZHK), Partner Site North , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]},{"name":"University Center of Cardiovascular Science, University Heart and Vascular Center Hamburg, University Medical Center Hamburg Eppendorf , Hamburg ,","place":["Germany"]},{"name":"Institute of Cardiovascular Sciences, University of Birmingham , Birmingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9838-8087","authenticated-orcid":false,"given":"Andr\u00e9","family":"Ziegler","sequence":"additional","affiliation":[{"name":"Roche Diagnostics International Ltd , Rotkreuz ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6488-2362","authenticated-orcid":false,"given":"Stefan","family":"Blankenberg","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research (DZHK), Partner Site North , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-0197","authenticated-orcid":false,"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research (DZHK), Partner Site North , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]},{"name":"Institute of Cardiovascular Sciences, University of Birmingham , Birmingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3379-2641","authenticated-orcid":false,"given":"Tanja","family":"Zeller","sequence":"additional","affiliation":[{"name":"University Hospital Schleswig-Holstein L\u00fcbeck, University of L\u00fcbeck, Institute for Cardiogenetics , L\u00fcbeck ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research (DZHK), Partner Site North , L\u00fcbeck ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7170-9509","authenticated-orcid":false,"given":"Renate B","family":"Schnabel","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research (DZHK), Partner Site North , Martinistrasse 52, 20251 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"2026052506013968500_euag096-B1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077209","article-title":"Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study","volume":"385","author":"Vinter","year":"2024","journal-title":"BMJ"},{"key":"2026052506013968500_euag096-B2","article-title":"Atrial fibrillation epidemiology, disparity and healthcare contacts: a population-wide study of 5.6 million individuals","volume":"7","author":"Chung","year":"2021","journal-title":"Lancet Reg Health\u2014Eur"},{"key":"2026052506013968500_euag096-B3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/europace\/euaa334","article-title":"Risk prediction of atrial fibrillation in the community combining biomarkers and genetics","volume":"23","author":"B\u00f6rschel","year":"2021","journal-title":"Europace"},{"key":"2026052506013968500_euag096-B4","doi-asserted-by":"crossref","first-page":"16743","DOI":"10.1038\/s41598-023-42331-7","article-title":"An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions","volume":"13","author":"Chua","year":"2023","journal-title":"Sci Rep"},{"key":"2026052506013968500_euag096-B5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028255","article-title":"Bone morphogenetic protein 10\u2014a novel biomarker to predict adverse outcomes in patients with atrial fibrillation","volume":"12","author":"Hennings","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026052506013968500_euag096-B6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033720","article-title":"Repeated measurement of the novel atrial biomarker BMP10 (Bone Morphogenetic Protein 10) refines risk stratification in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE Trial","volume":"13","author":"Gkarmiris","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026052506013968500_euag096-B7","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/cvr\/cvae067","article-title":"Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study","volume":"120","author":"Fabritz","year":"2024","journal-title":"Cardiovasc Res"},{"key":"2026052506013968500_euag096-B8","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1093\/eurheartj\/ehae611","article-title":"Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study","volume":"45","author":"Fabritz","year":"2024","journal-title":"Eur Heart J"},{"key":"2026052506013968500_euag096-B9","article-title":"Association of bone morphogenetic protein 10 and recurrent atrial fibrillation after catheter ablation","volume":"25","author":"Hennings","year":"2023","journal-title":"Europace"},{"key":"2026052506013968500_euag096-B10","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae028","article-title":"Disturbed atrial metabolism, shear stress, and cardiac load contribute to atrial fibrillation after ablation: AXAFA biomolecule study","volume":"26","author":"Chua","year":"2024","journal-title":"Europace"},{"key":"2026052506013968500_euag096-B11","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050471","article-title":"Role of angiopoietin-2 in vascular physiology and pathophysiology","volume":"8","author":"Akwii","year":"2019","journal-title":"Cells"},{"key":"2026052506013968500_euag096-B12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.hrthm.2020.04.027","article-title":"Role of angiopoietin-like protein 2 in atrial fibrosis induced by human epicardial adipose tissue: analysis using an organo-culture system","volume":"17","author":"Kira","year":"2020","journal-title":"Heart Rhythm"},{"key":"2026052506013968500_euag096-B13","first-page":"1868","article-title":"Bone morphogenetic protein-10 induces cardiomyocyte proliferation and improves cardiac function after myocardial infarction","volume":"115","author":"Sun","year":"2014","journal-title":"J Cell Biochem"},{"key":"2026052506013968500_euag096-B14","article-title":"High rate triggers increased atrial release of BMP10, A biomarker for atrial fibrillation and stroke, and BMP10 affects ventricular cardiomyocytes","volume":"18","author":"Sommerfeld","year":"2025","journal-title":"Circulation"},{"key":"2026052506013968500_euag096-B15","article-title":"Bone morphogenetic protein 10 and atrial fibrillation","volume":"51","author":"Liu","year":"2024","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2026052506013968500_euag096-B16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/0004563213510708","article-title":"Fibroblast growth factor 23","volume":"51","author":"Smith","year":"2014","journal-title":"Ann Clin Biochem"},{"key":"2026052506013968500_euag096-B17","doi-asserted-by":"crossref","first-page":"19502","DOI":"10.1002\/jcp.28548","article-title":"FGF23 regulates atrial fibrosis in atrial fibrillation by mediating the STAT3 and SMAD3 pathways","volume":"234","author":"Dong","year":"2019","journal-title":"J Cell Physiol"},{"key":"2026052506013968500_euag096-B18","article-title":"Cardiac FGF23 increases intracellular calcium in atrial myocytes and the susceptibility to atrial fibrillation decreased in FGF23\/MyHC\/+ mice","volume":"29","author":"Li","year":"2025","journal-title":"J Cell Mol Med"},{"key":"2026052506013968500_euag096-B19","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/s44161-022-00181-y","article-title":"Insulin-like growth factor-binding protein-7 (IGFBP7) links senescence to heart failure","volume":"1","author":"Zhang","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"2026052506013968500_euag096-B20","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026052506013968500_euag096-B21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.hroo.2025.02.017","article-title":"Association of atrial fibrillation burden and clinical profile with blood biomarkers: results from the ISOLATION Ablation Cohort","volume":"6","author":"Habibi","year":"2025","journal-title":"Heart Rhythm O2"},{"key":"2026052506013968500_euag096-B22","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.hrthm.2024.04.044","article-title":"Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation","volume":"21","author":"Serban","year":"2024","journal-title":"Heart Rhythm"},{"key":"2026052506013968500_euag096-B23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.hrthm.2020.11.028","article-title":"Insulin-like growth factor-binding protein 7 and risk of congestive heart failure hospitalization in patients with atrial fibrillation","volume":"18","author":"Blum","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026052506013968500_euag096-B24","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad200","article-title":"Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation","volume":"25","author":"Benz","year":"2023","journal-title":"Europace"},{"key":"2026052506013968500_euag096-B25","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"Europace"},{"key":"2026052506013968500_euag096-B26","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae204","article-title":"Atrial cardiomyopathy revisited\u2014evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)","volume":"26","author":"Goette","year":"2024","journal-title":"Europace"},{"key":"2026052506013968500_euag096-B27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139179","article-title":"Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation","volume":"5","author":"Reyat","year":"2020","journal-title":"JCI Insight"},{"key":"2026052506013968500_euag096-B28","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euac053.171","article-title":"BMP10 level helps to stratify risk of atrial fibrillation recurrence within one year after catheter ablation","volume":"24","author":"Zink","year":"2022","journal-title":"Europace"},{"key":"2026052506013968500_euag096-B29","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab724.0538","article-title":"Dynamic changes of cardiovascular biomarkers after ablation for atrial fibrillation: observations from AXAFA-AFNET5","volume":"42","author":"Chua","year":"2021","journal-title":"Eur Heart J"},{"key":"2026052506013968500_euag096-B30","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jamacardio.2016.1445","article-title":"Association of fibroblast growth factor 23 with atrial fibrillation in chronic kidney disease, from the chronic renal insufficiency cohort study","volume":"1","author":"Mehta","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026052506013968500_euag096-B31","doi-asserted-by":"crossref","first-page":"269S","DOI":"10.1177\/1076029618808909","article-title":"Biomarker profiling in stage 5 chronic kidney disease identifies the relationship between angiopoietin-2 and atrial fibrillation","volume":"24","author":"Bontekoe","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"2026052506013968500_euag096-B32","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.908053","article-title":"Blood-based biomarkers to search for atrial fibrillation in high-risk asymptomatic individuals and cryptogenic stroke patients","volume":"9","author":"Pal\u00e0","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026052506013968500_euag096-B33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/eurheartj\/ehac632","article-title":"Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation","volume":"44","author":"Hijazi","year":"2023","journal-title":"Eur Heart J"},{"key":"2026052506013968500_euag096-B34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/heartjnl-2024-324486","article-title":"Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure","volume":"111","author":"Ceelen","year":"2025","journal-title":"Heart"},{"key":"2026052506013968500_euag096-B35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCULATIONAHA.113.005499","article-title":"Fibroblast Growth Factor-23 and Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS)","volume":"130","author":"Mathew","year":"2014","journal-title":"Circulation"},{"key":"2026052506013968500_euag096-B36","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001082","article-title":"Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the atherosclerosis risk in communities study","volume":"3","author":"Alonso","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2026052506013968500_euag096-B37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12872-021-02138-8","article-title":"IGFBP7 and GDF-15, but not P1NP, are associated with cardiac alterations and 10-year outcome in an elderly community-based study","volume":"21","author":"Meessen","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"2026052506013968500_euag096-B38","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1038\/s41467-025-62218-7","article-title":"Biomarker panels for improved risk prediction and enhanced biological insights in patients with atrial fibrillation","volume":"16","author":"Meyre","year":"2025","journal-title":"Nat Commun"},{"key":"2026052506013968500_euag096-B39"},{"key":"2026052506013968500_euag096-B40","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026052506013968500_euag096-B41","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae298","article-title":"Spotlight on the 2024 ESC\/EACTS management of atrial fibrillation guidelines: 10 novel key aspects","volume":"26","author":"Rienstra","year":"2024","journal-title":"Europace"},{"key":"2026052506013968500_euag096-B42","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf318","article-title":"Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET\/EHRA consensus conference","volume":"27","author":"Svennberg","year":"2025","journal-title":"Europace"},{"key":"2026052506013968500_euag096-B43","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf019","article-title":"Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association","volume":"27","author":"Doehner","year":"2025","journal-title":"Europace"},{"key":"2026052506013968500_euag096-B44","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1093\/eurheartj\/ehae373","article-title":"Atrial fibrillation burden: a new outcome predictor and therapeutic target","volume":"45","author":"Becher","year":"2024","journal-title":"Eur Heart J"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euag096\/68291192\/euag096.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/5\/euag096\/68291192\/euag096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/5\/euag096\/68291192\/euag096.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T10:01:55Z","timestamp":1779703315000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euag096\/8678763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,6]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euag096","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,5]]},"article-number":"euag096"}}